Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Relmada Therapeutics Inc. sell Lokrim

Start price
€2.30
10:53 / 20%
Target price
-
19.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 19.08.25. The prediction end date can be changed by Lokrim at any time.
Performance without dividends (%)
Name 1w
Relmada Therapeutics Inc. -
iShares Core DAX® 3.054%
iShares Nasdaq 100 4.389%
iShares Nikkei 225® 5.386%
iShares S&P 500 2.955%

According to Lokrim what are the pros and cons of Relmada Therapeutics Inc. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Relmada Therapeutics Inc. diskutieren

Sell Relmada Therapeutics Inc.